Lisa Boris

845 total citations
9 papers, 145 citations indexed

About

Lisa Boris is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Lisa Boris has authored 9 papers receiving a total of 145 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Oncology. Recurrent topics in Lisa Boris's work include Glioma Diagnosis and Treatment (5 papers), Immunodeficiency and Autoimmune Disorders (2 papers) and Cancer-related cognitive impairment studies (2 papers). Lisa Boris is often cited by papers focused on Glioma Diagnosis and Treatment (5 papers), Immunodeficiency and Autoimmune Disorders (2 papers) and Cancer-related cognitive impairment studies (2 papers). Lisa Boris collaborates with scholars based in United States, Malaysia and Germany. Lisa Boris's co-authors include Pamela A. Welch, Steven M. Holland, Alexandra F. Freeman, Mark R. Gilbert, Brett Theeler, Mary Anne Jackson, Theo Heller, Camila D. Odio, Amanda K. Rudman Spergel and Rachel Bishop and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Allergy and Clinical Immunology and BMC Cancer.

In The Last Decade

Lisa Boris

9 papers receiving 144 citations

Peers

Countries citing papers authored by Lisa Boris

Since Specialization

Citations

This map shows the geographic impact of Lisa Boris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Boris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Boris more than expected).

Fields of papers citing papers by Lisa Boris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Boris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Boris. The network helps show where Lisa Boris may publish in the future.

Co-authorship network of co-authors of Lisa Boris

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Boris. A scholar is included among the top collaborators of Lisa Boris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Boris. Lisa Boris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	Imipridones and Dopamine Receptor Antagonism in the Therapeutic Management of Gliomas 2024 ·PubMed ·Eric Burton, (unknown), Lisa Boris, Desmond Brown, Brett Theeler	3
2	Exploring the prevalence and burden of sleep disturbance in primary brain tumor patients 2022 ·Neuro-Oncology Practice ·Amanda King, Dorela D. Shuboni‐Mulligan, Elizabeth Vera, Sonja Crandon, Alvina Acquaye, Lisa Boris, Eric Burton, Anna Choi, (unknown), Ewa Grajkowska, (unknown), Heather Leeper, Nicole Lollo, Marta Peñas-Prado, (unknown), Brett Theeler, (unknown), Jing Wu, Mark R. Gilbert, Terri S. Armstrong	10
3	Discovery of clinical and demographic determinants of symptom burden in primary brain tumor patients using network analysis and unsupervised clustering 2022 ·Neuro-Oncology Advances ·(unknown), Elizabeth Vera, (unknown), (unknown), Amanda King, Alvina Acquaye, Anna Choi, Heather Leeper, Tito R. Mendoza, Lisa Boris, Eric Burton, Nicole Lollo, (unknown), Marta Peñas-Prado, (unknown), (unknown), Jing Wu, Mark R. Gilbert, Terri S. Armstrong, Orieta Celiku	6
4	Challenges of imaging interpretation to predict oligodendroglioma grade: a report from the Neuro-Oncology Branch 2022 ·CNS Oncology ·Orwa Aboud, Ritu Shah, Elizabeth Vera, Eric Burton, Brett Theeler, Jing Wu, Lisa Boris, Martha Quezado, (unknown), (unknown), Mark R. Gilbert, Terri S. Armstrong, Marta Peñas-Prado	6
5	Phase I trial of TG02 plus dose-dense or metronomic temozolomide for recurrent anaplastic astrocytoma and glioblastoma in adults. 2019 ·Journal of Clinical Oncology ·(unknown), Ying Yuan, (unknown), Orwa Aboud, Marta Peñas-Prado, Brett Theeler, (unknown), Yuting Su, Ewa Grajkowska, (unknown), Lisa Boris, Christine Siegel, (unknown), Nancy Garren, (unknown), Terri S. Armstrong, Mark R. Gilbert	8
6	Clinical decision making in the era of immunotherapy for high grade-glioma: report of four cases 2018 ·BMC Cancer ·(unknown), Martha Quezado, Nancy Garren, Lisa Boris, Christine Siegel, Osório Lopes Abath Neto, Brett Theeler, Deric M. Park, Edjah K. Nduom, Kareem A. Zaghloul, Mark R. Gilbert, Jing Wu	31
7	ACTR-69. PHASE I TRIAL OF TG02 PLUS DOSE-DENSE OR METRONOMIC TEMOZOLOMIDE FOR ADULTS WITH RECURRENT ANAPLASTIC ASTROCYTOMA AND GLIOBLASTOMA 2017 ·Neuro-Oncology ·Jing Wu, (unknown), (unknown), Lisa Boris, Nancy Garren, Christine Siegel, Ewa Grajkowska, Brett Theeler, Deric M. Park, (unknown), Terri S. Armstrong, Ying Yuan, Mark R. Gilbert	3
8	Endemic mycoses in patients with STAT3-mutated hyper-IgE (Job) syndrome 2015 ·Journal of Allergy and Clinical Immunology ·Camila D. Odio, Ki Lee Milligan, (unknown), Amanda K. Rudman Spergel, Rachel Bishop, Lisa Boris, Amanda Urban, Pamela A. Welch, Theo Heller, David E. Kleiner, Mary Anne Jackson, Steven M. Holland, Alexandra F. Freeman	50
9	Lung Parenchyma Surgery in Autosomal Dominant Hyper-IgE Syndrome 2013 ·Journal of Clinical Immunology ·Alexandra F. Freeman, Ellen D. Renner, (unknown), (unknown), Kenneth N. Olivier, Amy P. Hsu, Beate Hagl, (unknown), Joie Davis, Beatriz E. Marciano, Lisa Boris, Pamela A. Welch, Julie Sawalle‐Belohradsky, Bernd H. Belohradsky, King F. Kwong, Steven M. Holland	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact